Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.

McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD, Barker MA, Arnold S, Simms LA, Leggett BA, Young J, Jass JR.

Fam Cancer. 2004;3(2):101-7.

PMID:
15340260
2.
3.

Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.

Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB.

J Med Genet. 2012 Mar;49(3):151-7. doi: 10.1136/jmedgenet-2011-100714. Review.

PMID:
22368298
4.

New aspects in molecular diagnosis of Lynch syndrome (HNPCC).

Fridrichova I.

Cancer Biomark. 2006;2(1-2):37-49. Review.

PMID:
17192058
5.

MSI-testing in hereditary non-polyposis colorectal carcinoma (HNPCC).

Müller A, Edmonston TB, Dietmaier W, Büttner R, Fishel R, Rüschoff J.

Dis Markers. 2004;20(4-5):225-36. Review.

6.

Epigenetics, mismatch repair genes and colorectal cancer.

Wheeler JM.

Ann R Coll Surg Engl. 2005 Jan;87(1):15-20. Review.

7.

Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome.

Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN.

Fam Cancer. 2005;4(3):255-65. Review.

PMID:
16136387
8.

DNA mismatch repair status may influence anti-neoplastic effects of butyrate.

Coxhead JM, Williams EA, Mathers JC.

Biochem Soc Trans. 2005 Aug;33(Pt 4):728-9. Review.

PMID:
16042586
9.

Clinical implications of microsatellite instability in sporadic colon cancers.

Sinicrope FA, Sargent DJ.

Curr Opin Oncol. 2009 Jul;21(4):369-73. doi: 10.1097/CCO.0b013e32832c94bd. Review.

10.

Biology of colorectal cancer.

Arvelo F, Sojo F, Cotte C.

Ecancermedicalscience. 2015 Apr 9;9:520. doi: 10.3332/ecancer.2015.520. eCollection 2015. Review.

11.

Genetic profiling of colon cancer.

Neibergs HL, Hein DW, Spratt JS.

J Surg Oncol. 2002 Aug;80(4):204-13. Review. No abstract available.

PMID:
12210035
12.

The genetics of hereditary non-polyposis colorectal cancer and non-polypotic colon cancer.

Peltomäki P.

Adv Exp Med Biol. 1999;470:95-8. Review. No abstract available.

PMID:
10709678
13.

Cytotoxic and targeted therapy for hereditary cancers.

Iyevleva AG, Imyanitov EN.

Hered Cancer Clin Pract. 2016 Aug 23;14(1):17. doi: 10.1186/s13053-016-0057-2. eCollection 2016. Review.

14.

Molecular genetics of colorectal cancer.

Bogaert J, Prenen H.

Ann Gastroenterol. 2014;27(1):9-14. Review.

Supplemental Content

Support Center